Showing 7111-7120 of 7634 results for "".
- Envy Medical and Libbs Farmaceutical Plan Strategic Marketing, Sales and Distribution Agreement For Brazilhttps://practicaldermatology.com/news/20140723-envy_medical_and_libbs_farmaceutical_plan_strategic_marketing_sales_and_distribution_agreement_for_brazil/2459159/Envy Medical and Libbs Farmaceutical made an agreement to manufacture, market and sell Envy's proprietary Lumixyl® Brightening Creme throughout the country of Brazil. This represents significant agreement with Libbs, a leader in the sales and supply of pharmaceutical products, it also rep
- Psoriasis Foundation Awards 13 Research Fellowshipshttps://practicaldermatology.com/news/20140721-psoriasis_foundation_awards_13_research_fellowships/2459162/The National Psoriasis Foundation awarded 13 residents and medical students each a one-year, $50,000 fellowship to study psoriasis. The fellowships aim to increase the number of scientists studying and treating psoriatic disease by encouraging promising doctors to dedicate their careers to the study
- Benefits of Multi-beam OCT Presented at the 24th Annual Education Week for Practical Dermatology and Venereologyhttps://practicaldermatology.com/news/20140718-benefits_of_multi-beam_oct_presented_at_the_24th_annual_education_week_for_practical_dermatology_and_venereology/2459164/Michelson Diagnostics, a UK based medical device company, announced that a session on the benefits of the multi-beam OTC —"Evidence for OCT diagnostics" — will be presented during the 24th Annual Education Week for Practical Dermatology and Venereology, known as Fortbildungswoche, in Munich, Germ
- Viscot Offers New White Ink Markershttps://practicaldermatology.com/news/20140717-viscot_offers_new_white_ink_markers/2459165/Viscot Medical introduced White E•Z Removable Ink™to complement their existing green and red E•Z Removable Ink™ markers. E•Z Removable Ink™ comes off easily with an alcohol swab or water. E•Z Removable Ink™ eliminates the problem of patient
- LEO Pharma and KLOX Technologies Strike Global Dermatology Dealhttps://practicaldermatology.com/news/20140715-leo_pharma_and_klox_technologies_strike_global_dermatology_deal/2459167/LEO Pharma A/S and KLOX Technologies Inc. have entered into a worldwide license and joint venture agreement, excluding Canada, to further develop and commercialize KLOX's BioPhotonic technology platform in dermatology, which includes a CE-approved treatment for moderate to sever
- Promius Pharma Launches New Physician Portal to Track Patient Progress on Zenatanehttps://practicaldermatology.com/news/20140715-promius_pharma_launches_new_physician_portal_to_track_patient_progress_on_zenatane/2459169/A new web-based provider portal from Promius Pharma allows physicians to follow a patient's progress while taking Zenatane™(isotretinoin capsules USP) AB rated to Accutane. Designed to allow any authorized prescriber using the Promius Promise to obtain easy, instant access to secure patient data rel
- Trevi Therapeutics Initiates Pivotal Study of Nalbuphine ER in Uremic Pruritushttps://practicaldermatology.com/news/20140714-trevi_therapeutics_initiates_pivotal_study_of_nalbuphine_er_in_uremic_pruritus/2459171/Trevi Therapeutics recently released data from its successfully completed Phase 1 trial in which Nalbuphine ER was well tolerated in hemodialysis patients and established proof-of-concept for Nalbuphine ER in treating uremic pruritus. Trevi's President and Chief Executive Officer, Jennife
- Aclaris Therapeutics Announces Positive Results from Phase II study of Seborrheic Keratosis Treatmenthttps://practicaldermatology.com/news/20140702-aclaris_therapeutics_announces_positive_results_from_phase_ii_study_of_seborrheic_keratosis_treatment/2459181/Aclaris Therapeutics, Inc. announced positive results from a Phase II clinical trial of the its lead drug, A-101. In the trial, A-101 demonstrated clinically and statistically significant improvements in clearing seborrheic keratoses (SK). The double-bl
- Merz Signs Licensing Agreement with Brickell Biotech for Development of a Novel Retinoid Therapyhttps://practicaldermatology.com/news/20140702-merz_signs_licensing_agreement_with_brickell_biotech_for_development_of_a_novel_retinoid_therapy/2459182/Merz North America, Inc. signed an agreement with Brickell Biotech, Inc. granting Merz an exclusive North American license with certain additional international rights to develop and commercialize, a completely novel retinoid compound for the treatment of skin conditions respons
- Merz to Acquire Ulthera, Inc.https://practicaldermatology.com/news/20140630-merz_to_acquire_ulthera_inc/2459184/Merz and Ulthera have entered a definitive merger agreement pursuant to which Merz will acquire Ulthera, Inc, a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications using its therapeutic ultrasound platform technology. Valued